Soligenix signs $10M equity purchase agreement with accredited institutional...
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has entered...
View ArticleEuropean Commission grants orphan drug designation to SGX301 for treatment of...
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European...
View ArticleResearchers use advanced photodynamic therapy to combat ovarian cancer in...
Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved...
View ArticleNIAID exercises option to advance development of Soligenix's heat stabilized...
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National...
View ArticleSoligenix obtains additional funding from NIAID to advance development of...
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National...
View ArticleSoligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in...
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today it has completed...
View ArticleNew combination approach to eradicate established tumors
A laboratory study conducted at Leiden University Medical Center in the Netherlands has found that immunotherapy can be efficiently combined with photodynamic therapy (PDT) to eradicate established...
View ArticleSoligenix reports positive results from SGX942 Phase 2 trial in patients with...
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results...
View ArticleNSCLC treatments market in Europe expected to cross US$ 3 billion by 2019
According to recently published Pharmaion report, "Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020", the non-small cell lung cancer (NSCLC) treatments market in Europe is...
View ArticleCombining nanomedicine with two anticancer treatments could improve outcomes...
A nanoparticle drug-delivery system that combines two complementary types of anticancer treatment could improve outcomes for patients with pancreatic cancer and other highly treatment-resistant tumors...
View ArticleCombining photoimmunotherapy and gene transduction effective against elusive...
Researchers report photoimmunotherapy to be effective against elusive gastric cancer cells following transduction with the gene that expresses the extracellular domain protein of HER2. The results are...
View ArticleNew photo-switchable molecule for PDT could help treat rapidly growing tumors
Photoswitchable agents might reduce side effects of a chemotherapy. So far, photodynamic therapies have been dependent on oxygen in the tissue. But hardly any oxygen exists in malignant, rapidly...
View ArticleNEI-funded study analyzes outcomes of anti-VEGF therapy for AMD
In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five...
View ArticleClinical study finds two topical skin creams as effective noninvasive...
Basal cell carcinoma is one of the most common cancers and its incidence is increasing worldwide, putting a significant burden on health services. Topical treatments are available for superficial basal...
View ArticlePhotodynamic therapy effective in treating porphyrias but can be severely...
Severe paleness and photosensitivity are two symptoms of a rare group of hereditary diseases that affect haem, a substance in the blood. While these metabolic disorders - known as the porphyrias - are...
View ArticleSoligenix announces encouraging preliminary results of heat stable Ebola vaccine
A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.
View ArticleScientists develop novel multifunctional platform to integrate imaging and...
Physicists from The University of Texas at Arlington are leading a multidisciplinary project with The University of Texas Southwestern Medical Center in Dallas and The University of Texas MD Anderson...
View ArticleNovel therapy offers hope for effective treatment of intractable metastatic...
Cancer treatments that mobilize the body's immune system to fight the disease have generated a lot of excitement in the past few years.
View ArticleNovel microwave-induced photodynamic therapy could target deeply situated tumors
Physicists at The University of Texas at Arlington have shown that using microwaves to activate photosensitive nanoparticles produces tissue-heating effects that ultimately lead to cell death within...
View ArticleUPV participates in Lumiblast project to develop novel treatments for...
The Polytechnic University of Valencia is taking part in Lumiblast, a European project to develop an innovative approach to hard-to-treat brain tumours like glioblastomas.
View Article